Comments*

 
  • Annals of the New York Academy of Sciences

  • Annals

    Ecological Economics Reviews

    This inaugural issue of a new Annals series contains reviews on topics that are at the crossroads of ecology and economics.

  • Recent Annals 

    February 2010

    Addiction Reviews 2

    Edited by George R. Uhl (Molecular Neurobiology, National Institutes of Health, Baltimore, Maryland).

    Included in this Annals issue are topics relevant to specific substances that also provide important lessons for addiction to any substance.

    Advance online publication

    February 2010

    Ecological Economics Reviews

    Edited by Karin E. Limburg (SUNY College of Environmental Science and Forestry, Syracuse, New York) and Robert Costanza (Gund Institute for Ecological Economics, University of Vermont, Burlington, VT)

    The inaugural issue of a series of reviews on the theory, policy, and implementation of sustainability and sustainable development, with a focus on the economic, social, and environmental challenges facing the world today.

    January 2010

    The Year in Neurology 2

    Edited by Richard T. Johnson (Johns Hopkins University School of Medicine, Baltimore, Maryland)

    This second volume in The Year in Neurology series presents reviews covering novel approaches to our understanding of neurological diseases through basic science and clinical approaches.

    January 2010

    The Year in Immunology 2

    Edited by Noel R. Rose (Center for Autoimmune Disease Research, The Johns Hopkins University, Baltimore, Maryland)

    This volume of immunology reviews focuses on novel approaches to our understanding of immunoregulatory mechanisms.

    December 2009

    Cytokine Therapies: Novel Approaches for Clinical Indications

    Edited by Raymond P. Donnelly (Center for Drug Evaluation & Research (CDER), Food and Drug Administration, Rockville, Maryland)

    This volume includes presentations by experts from academia, industry and government on the scientific and clinical basis for the successes and failures of recombinant cytokines and cytokine antagonists as therapeutic agents.

    December 2009

    Chernobyl: Consequences of the Catastrophe for People and the Environment

    Written by Alexey V. Yablokov (Center for Russian Environmental Policy, Moscow, Russia), Vassily B. Nesterenko, and Alexey V. Nesterenko (Institute of Radiation Safety, Minsk, Belarus). Consulting Editor Janette D. Sherman-Nevinger (Environmental Institute, Western Michigan University, Kalamazoo, Michigan).

    This volume contains a comprehensive summary of all the scientific literature related to the Chernobyl disaster, including a vast array of reports published in Russian and Ukrainian.

    November 2009

    Pepducin symposium explores a new approach to GPCR modulation

    Jacquelyn Miller (MacDougall Biomedical Communications, Wellesley, Massachusetts), Anika Agarwal and Athan Kuliopulos (Tufts Medical Center, Boston, Massachusetts), Lakshmi A. Devi (Mount Sinai School of Medicine, New York, New York), Kellen Fontanini and James A. Hamilton (Boston University School of Medicine, Boston, Massachusetts), Jean-Philippe Pin (University of Montpellier, Montpellier, France), Denis C. Shields (The University College of Dublin, Dublin, Ireland), C. Arnold Spek (University of Amsterdam, Amsterdam, the Netherlands), Thomas P. Sakmar (The Rockefeller University, New York, New York), and Stephen W. Hunt III (Ascent Therapeutics, Cambridge, Massachusetts).

    The inaugural Pepducin Science Symposium in Cambridge, Massachusetts on March 8–9, 2009 provided the opportunity for an international group of scientists to present and discuss how pepducins modulate G protein–coupled receptor-related research.

    Free online access meeting report

    November 2009

    Biomarkers in Brain Disease

    Edited by Simon Lovestone (King's College, University of London)

    Experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders, and the logistical, regulatory, and funding challenges experienced by scientists working on clinical trials for biomarkers.

    November 2009

    Glucocorticoids and Mood: Clinical Manifestations, Risk Factors, and Molecular Mechanisms

    Edited by Lewis L. Judd (Department of Psychiatry, University of California, San Diego) and Esther Sternberg (Integrative Neural Immune Program, Section on Neuroendocrine Immunology and Behavior, NIMH, NIH, Bethesda, Maryland)

    New basic research provides important insights into possible mechanisms of action that promote negative sequelae in vulnerable and susceptible patients who receive glucocorticoid treatment.

    October 2009

    Hypoxia and Consequences: From Molecule to Malady

    Edited by Chris Peers (School of Medicine, University of Leeds, Leeds, UK), Gabriel G. Haddad (University of California, San Diego, California), and Navdeep S. Chandel (Northwestern University, Evanston, Illinois)

    This volume explores the transcriptional and pathophysiological responses to hypoxia and of the sensing mechanisms responsible for detection of oxygen level changes in the body.